For researchers designing in vitro or preclinical study protocols, understanding the research application of each compound is important
(2018) 97:e13543
For example, if your protocol requires 200mg three times weekly, a single 30mL vial at 100mg/mL concentration provides 15 doses (5 weeks of supply)
Provider-Guided Safety Considerations for Hypertensive Patients Patients with uncontrolled hypertension (consistently above 160/100 mmHg) should achieve better blood pressure management before initiating GLP-1 therapy
Schucht P, Raineteau O, Schwab OE, Fouad K
SELECT Trial Cardiovascular Disease 20% reduction in the risk of cardiovascular events 37% risk reduction in a broader set of secondary outcomes (including cardiovascular death and stroke) FLOW Trial Chronic Kidney Disease: Novo Nordisks clinical trial , which enrolled 3,533 people with type 2 diabetes and CKD, was ended early as a result of clear efficacy